HUTCHMED (China) Limited
General ticker "HMDCF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.8B (TTM average)
HUTCHMED (China) Limited follows the US Stock Market performance with the rate: 14.5%.
Estimated limits based on current volatility of 0.1%: low 2.82$, high 2.82$
Factors to consider:
- Total employees count: 2025 as of 2022
Short-term HMDCF quotes
Long-term HMDCF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $838.00MM | $630.20MM | $549.32MM |
| Operating Expenses | $819.62MM | $670.81MM | $603.99MM |
| Operating Income | $18.38MM | $-40.61MM | $-54.66MM |
| Non-Operating Income | $87.23MM | $85.97MM | $576.77MM |
| Interest Expense | $0.76MM | $2.87MM | $2.87MM |
| R&D Expense | $302.00MM | $212.11MM | $163.96MM |
| Income(Loss) | $105.60MM | $45.36MM | $522.11MM |
| Taxes | $4.51MM | $7.19MM | $63.70MM |
| Profit(Loss)* | $100.78MM | $37.73MM | $457.58MM |
| Stockholders Equity | $730.54MM | $759.93MM | $1,237.76MM |
| Inventory | $50.26MM | $50.38MM | $41.12MM |
| Assets | $1,279.77MM | $1,274.20MM | $1,752.87MM |
| Operating Cash Flow | $219.26MM | $0.50MM | $-64.75MM |
| Capital expenditure | $32.61MM | $17.93MM | $14.17MM |
| Investing Cash Flow | $-291.14MM | $-96.06MM | $-29.45MM |
| Financing Cash Flow | $48.66MM | $-30.67MM | $7.85MM |
| Earnings Per Share** | $0.12 | $0.04 | $0.53 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.